James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

In-App Facebook Retail Could Be Huge for FB Stock

FB stock may not have moved much on its shopping change, but the new Facebook retail option is different than the rest in a big way.

Why Banco Santander Brasil SA (BSBR), JetBlue Airways Corporation (JBLU) and Vale SA (VALE) Are 3 of Today’s Worst Stocks

Banco Santander Brasil (BSBR), JetBlue Airways (JBLU) and Vale (VALE) couldn't even buy a friend on Wall Street on Tuesday. Here's the deal.

Why Infosys Ltd (INFY), Twitter Inc (TWTR) and VMware, Inc. (VMW) Are 3 of Today’s Worst Stocks

Infosys (INFY), Twitter (TWTR) and VMware (VMW) all got their clock cleaned on the first trading day of the new week. Here's the deal.

What’s Next for VMWare Stock After the Dell-EMC Deal? (VMW)

VMWare stock is getting crushed under the apparent weight of bad news, but it's not that simple.

Eli Lilly and Co: Today’s Plunge in LLY Stock Is NOT a Buying Opportunity

Eli Lilly (LLY) stock is deep in the red on Monday thanks to bad news regarding cholesterol therapy evacetrapib, but that's not the only worry.